Virovance

Virovance is an AI-driven oncology biotechnology company pioneering the discovery of novel CDK-targeting therapeutics. Our proprietary ViroCoreAI™ platform integrates advanced machine learning, agentic AI, and molecular dynamics to design, rank, and optimize small molecules for selectivity, potency, and druggability. We focus on developing preclinical assets for development and strategic partnerships, combining cutting-edge computation with lean validation strategies.